Prognostic Worth of Epidermal Growth Factor Receptor (EGFR) in Patients with Head and Neck Tumors
Open Access
- 12 November 2020
- journal article
- research article
- Published by Wiley in Journal of Cancer Epidemiology
- Vol. 2020, 1-7
Abstract
Introduction. Head and neck tumors (HNT) are tumors that normally occur at the head and neck region of the body. Epidermal growth factor receptor (EGFR) has been found to be highly expressed in breast and other tumors; therefore, there is the need to investigate the level of EGFR expression among patients with head and neck tumors in Ghana. Method. The level of EGFR expression was determined in head and neck tumor and control head and neck tissues with quantitative real-time PCR and immunohistochemistry analysis. Results. The level of EGFR expressions was high in tumor tissues than in the control tissues. There was a significant difference of value 0.025 among the ages >40 and ≤ 40 when the high and low level of EGFR was compared in the head and neck malignant tumor. The area under the curve for the high expression of EGFR among the malignant head and neck tumors was 0.901 with a specificity of 86.4%. Conclusion. EGFR can serve as a prognostic marker in monitoring patients with HNT as well as a molecular therapeutic target.Keywords
Funding Information
- University of Cape Coast
This publication has 20 references indexed in Scilit:
- Immunohistochemistry Analysis of CD44, EGFR, and p16 in Oral Cavity and Oropharyngeal Squamous Cell CarcinomaOtolaryngology–Head and Neck Surgery, 2017
- The prognostic implication of the expression of EGFR, p53, cyclin D1, Bcl-2 and p16 in primary locally advanced oral squamous cell carcinoma cases: a tissue microarray studyMedical Oncology, 2016
- The head and neck cancer immune landscape and its immunotherapeutic implicationsJCI Insight, 2016
- Evaluation of EGFR as a prognostic and diagnostic marker for head and neck squamous cell carcinoma patientsOncology Letters, 2016
- Infectious complications and ventilation tubes in pediatric cochlear implant recipientsThe Laryngoscope, 2015
- The Nucleus-Localized Epidermal Growth Factor Receptor Is SUMOylatedBiochemistry, 2015
- Epidermal growth factor receptor protein overexpression and gene amplification are associated with aggressive biological behaviors of esophageal squamous cell carcinomaOncology Letters, 2015
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Combined analysis of HPV‐DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancerInternational Journal of Cancer, 2007
- Expression of EGF, EGFR and PCNA in laryngeal lesionsThe Journal of Laryngology & Otology, 1995